The American Journal of Managed Care

Rescue Therapy With Rozanolixizumab Promising in Triple-Seronegative MG

Takenobu Y, Kikuchi T, Ishikawa D, et al. Rozanolixizumab as rescue therapy in triple seronegative refractory generalized ...

Galectin Therapeutics Presented NAVIGATE Trial Results at the American Association for the Study of Liver Diseases (AASLD) 2025 Annual Meeting

New biomarker analyses from the NAVIGATE trial demonstrated consistent antifibrotic effects of belapectin 2 mg/kgUsing established criteria for clinically meaningful worsening, a lower proportion of ...
autoevolution

EVs Nemesis? MG EXE: ION Is a Digital Concept That Makes Its Own Ionic Wind To Get Moving

MG’s EX code meant “experimental,” and EX135 proved it at 203.5 mph; EXE : ION revives that nerve with electroaerodynamic thrust inspired by MIT’s solid-state f ...
ahajournals.org

ApTOLL 0.2 mg/kg Reduces Infarct Growth and Edema in Acute Ischemic Stroke: A Secondary Analysis of the APRIL Trial

This study leverages the APRIL (A Double-Blind, Placebo-Controlled, Randomized, Phase Ib/IIa Clinical Study of ApTOLL for the Treatment of Acute Ischemic Stroke) trial, which was a phase 1b/2a study ...